B of A Securities Maintains Buy on Guardant Health, Raises Price Target to $40
B of A Securities Maintains Buy on Guardant Health, Raises Price Target to $40
b of A證券維持對Guardant Health的買入評級，將價格目標上調至40美元。
B of A Securities analyst Michael Ryskin maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $28 to $40.
B of A證券分析師Michael Ryskin 維持對 Guardant Health（納斯達克代碼：GH）的買入評級，並將目標價從28美元上調至40美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。